Therapeutic Occupancy of the D2/3-Preferring Dopamine Receptor Agonist 
Pramipexol in Brains of Patients with Parkinson's Disease ([18F]-Fallypride PET 
Study)

Deutschlander, A.; La Fougere, C.; Xiong, G. M.; Bötzel, K.; Gründer, G.; Cumming, P.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Therapeutic Occupancy of the D2/3-Preferring Dopamine Receptor Agonist Pramipexol in Brains of Patients with Parkinson's Disease ([18F]-Fallypride PET Study)

MPS-Authors

Deutschlander, A.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Deutschlander, A., La Fougere, C., Xiong, G. M., Bötzel, K., Gründer, G., & Cumming, P. (2012). Therapeutic Occupancy of the D2/3-Preferring Dopamine Receptor Agonist Pramipexol in Brains of Patients with Parkinson's Disease ([18F]-Fallypride PET Study). Neurology, 78(Suppl. 1): doi: 10.1212WNL.78.1 MeetingA.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-8C9A-A

Abstract

There is no abstract available